North Carolina Community Mental Health Medical Directors' Network

The UNC Center for Excellence in Community Mental Health has partnered with the North Carolina Area Health Education Centers (NC AHEC), and the North Carolina Psychiatric Association and established the North Carolina Community Mental Health Medical Directors' Network. The Network supports psychiatrists and other physicians in their new role as leaders of clinical care in the restructured mental health system.

This first-of-its-kind statewide-organization offers medical directors from the newly formed Critical Access Behavioral Health Agencies (CABHAs) and Local Management Entities (LMEs), as well as psychiatrists affiliated with Community Care of North Carolina (CCNC):

  • Professional education about evidence-based treatment
  • Timely information about the state's evolving system of care
  • Online access to other community mental health medical directors as they pursue like goals in their community -Medical Directors' Listserv.
  • Support in providing professional development for medical leadership and incorporating evidence-based, cost-effective clinical care into their agencies' practice
  • Continued integration and communication between various levels of the system: CABHAs, LMEs, CCNC, and the North Carolina Division of Mental Health.

"It's vital that medical directors have the support they need to fashion this new approach to better mental health care," says John Gilmore, MD, director of the UNC Center for Excellence in Community Mental Health. "And providing psychiatrists with what they need to be effective leaders is what the Center is all about."

For more information about the Medical Directors' Network or to join the listserv, please contact Alice Lockhart at alice_lockhart@med.unc.edu


Upcoming Events with Medical Directors' Programs:

Mar
23
10:30 am - 3:00 pm



ABOUT CABHAs:
In January 2011, North Carolina’s public mental health system was restructured around Critical Access Behavioral Health Agencies (CABHAs), sites of comprehensive clinical evaluation and integrated treatment. Each CABHA is required to have a medical director to oversee the clinical enterprise, ensuring that clinical care being delivered by the agency is evidence-based, appropriate for the clinical needs of each patient, and cost-effective.

Once the hallucinations or delusions are controlled by medications, the person should be able to return to normal and get on with his or her life.

To a degree this may be true, but for some people with schizophrenia, medications do not completely control the positive symptoms (hallucinations, delusions, and disorganized behavior), nor do they have much effect on the negative symptoms (brief or no replies in conversation, lack of motivation, inability to experience pleasure, blunted affect), or cognitive symptoms (impaired attention, memory, and executive functioning). Given that these other symptoms can affect a person's ability to function as much as or even more than the positive symptoms, it's clear that the medications we have currently are not always enough to return a person to full recovery. That's why we recommend a team approach to treatment that includes medications and psychosocial interventions.